New Zealand-designed artificial intelligence framework MedicMind which enables the development and design of AI without coding has been used to develop an advance set of algorithms to detect a range of common eye diseases. Findings are published on Clinical and Experimental Ophthalmology. The Dunedin-based research was part of an initiative to tackle growing ageing population and degenerative eye diseases, oDocs Eye Care director Dr Hong Sheng Chiong says. A total of 4435 images were used for developing the artificial intelligence and its underlying algorithm. The average accuracy was 80 percent, with sensitivity of 75 percent and specificity of 89 percent.…

23 Oct:  1151 | The Munich Regional Court has found Fisher & Paykel Healthcare breached a patent held by rival ResMed

Internationally respected Physics Professor Phil Butler has been announced as the 2018 recipient of the University of Canterbury (UC) Innovation Medal, the highest award the University can bestow to an outstanding innovator.

A new study finds that bacteria develop antibiotic resistance up to 100,000 times faster when exposed to the world’s most widely used herbicides, Roundup (glyphosate) and Kamba (dicamba) and antibiotics compared to without the herbicide.

Invented in Christchurch, the MARS spectral x-ray scanner will revolutionise medical imaging globally, and the diagnosis and treatment of diseases such as cancer and heart disease, because it provides far greater detail of the body’s chemical components.

A Wellington-based start-up is poised to disrupt a $40 billion antibodies industry by creating a faster, cheaper and humane way of testing for substances reports Farah Hancock for Newsroom.

PharmaZen, a manufacturer of plant and animal-based health supplements, turned to a record first-half profit as it reaped the benefit of earlier investments

Engineers from Massachusetts Institute of TechnologyMIT have developed a streamlined prosthetic foot that lets wearers walk with a fluid motion, and can be manufactured at a low cost.

Listed cannabis company Creso Pharma is set to launch its chronic pain product into the New Zealand market after signing an agreement with a key distributor.

A Kiwi biotechnology company which has found a way to grow bigger-than-A5 sheets of replacement human skin says the product might be ready to start clinical trials on burn patients in 2020 or 2021

Sir Ray Avery reckons we all start life with 30,000 days. By his calculation he has 4795 left so there is still a chance for him to leave a legacy from the whole country, he reckons